FATE THERAPEUTICS INC Stock Issued During Period, Shares, Conversion of Convertible Securities
FATE THERAPEUTICS INC (FATE) reported Stock Issued During Period, Shares, Conversion of Convertible Securities of 3.68 million shares for the 0-month period ending 2013-10-04, per its 10-K filed 2014-03-17.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2014-03-17
- 2013-10-04: Stock Issued During Period, Shares, Conversion of Convertible Securities 0 month 3.68M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities 0 month |
|---|---|
| 2013-10-04 | 3.68M shares 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |